These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 29614506)

  • 1. Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis via MDM2.
    He FF; You RY; Ye C; Lei CT; Tang H; Su H; Zhang C
    Cell Physiol Biochem; 2018; 46(2):451-460. PubMed ID: 29614506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway.
    Ye C; Tang H; Zhao Z; Lei CT; You CQ; Zhang J; Gao P; He FF; Chen S; Wang YM; Zhang C; Su H
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F760-F768. PubMed ID: 28100501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
    Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
    J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAD2B-mediated SnoN downregulation is implicated in fibroblast activation and tubulointerstitial fibrosis.
    Tang H; Su H; Fan D; Ye C; Lei CT; Jiang HJ; Gao P; He FF; Zhang C
    Am J Physiol Renal Physiol; 2016 Jul; 311(1):F207-16. PubMed ID: 27122545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renalase Protects against Renal Fibrosis by Inhibiting the Activation of the ERK Signaling Pathways.
    Wu Y; Wang L; Deng D; Zhang Q; Liu W
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.
    Cho JH; Ryu HM; Oh EJ; Yook JM; Ahn JS; Jung HY; Choi JY; Park SH; Kim YL; Kwak IS; Kim CD
    PLoS One; 2016; 11(9):e0162186. PubMed ID: 27607429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
    Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
    Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
    PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
    Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B
    Nephron; 2022; 146(1):110-120. PubMed ID: 34724669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
    Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y
    Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
    Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
    Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
    Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
    Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and role of SCAI during renal fibrosis and epithelial-to-mesenchymal transition.
    Fintha A; Gasparics Á; Fang L; Erdei Z; Hamar P; Mózes MM; Kökény G; Rosivall L; Sebe A
    Am J Pathol; 2013 Feb; 182(2):388-400. PubMed ID: 23178076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
    PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-ATPase promotes transforming growth factor-β-induced epithelial-mesenchymal transition of rat proximal tubular epithelial cells.
    Cao X; Yang Q; Qin J; Zhao S; Li X; Fan J; Chen W; Zhou Y; Mao H; Yu X
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1121-32. PubMed ID: 22129967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy.
    Li A; Zhang X; Shu M; Wu M; Wang J; Zhang J; Wang R; Li P; Wang Y
    Phytomedicine; 2017 Jul; 30():28-41. PubMed ID: 28545667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
    Ponnusamy M; Zhou X; Yan Y; Tang J; Tolbert E; Zhao TC; Gong R; Zhuang S
    J Pharmacol Exp Ther; 2014 Aug; 350(2):243-56. PubMed ID: 24833701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.